The clinical relevance of broad mutational screening of myeloproliferative neoplasms at diagnosis

INTRODUCTION: Myeloproliferative neoplasm (MPN) is a heterogenous group of hematological malignancies including polycythemia vera (PV), essential thrombocythemia (ET) and primary myelofibrosis (PMF). JAK2V617F is the most frequent driver mutation in all three entities, but in PMF and ET mutations in...

Descripción completa

Detalles Bibliográficos
Autores principales: Pettersson, Helna, Adamsson, Jenni, Johansson, Peter, Nilsson, Staffan, Palmqvist, Lars, Andréasson, Björn, Asp, Julia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10451068/
https://www.ncbi.nlm.nih.gov/pubmed/37637067
http://dx.doi.org/10.3389/fonc.2023.1190305

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10451068/
https://www.ncbi.nlm.nih.gov/pubmed/37637067
http://dx.doi.org/10.3389/fonc.2023.1190305

Ejemplares similares